Concepedia

Joerg Schlingemann

JS

Statistics

Publications

8

Citations

475

H-Index

8

Active since

2021

Affiliations

Merck KGaA, Darmstadt (Germany)(Current)

AstraZeneca (United Kingdom)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Pfizer (United Kingdom)

United States Pharmacopeial Convention

Joerg Schlingemann is an author at Merck KGaA, Darmstadt (Germany) specializing in pharmacy, nitrosamine impurity analysis, and pharmacology.

ORCID

Publications per year

2021–2025

8

Publications

8

The Landscape of Potential Small and Drug Substance Related Nitrosamines in Pharmaceuticals

Joerg Schlingemann, Michael J. Burns, David J. Ponting et al. · Journal of Pharmaceutical Sciences · 2022 · 127 citations · Full text

, , +13

A Nitrite Excipient Database: A Useful Tool to Support N-Nitrosamine Risk Assessments for Drug Products

Ruth Boetzel, Joerg Schlingemann, Sebastian Hickert et al. · Journal of Pharmaceutical Sciences · 2022 · 96 citations · Full text

, , +14

The Nitrosamine “Saga”: Lessons Learned from Five Years of Scrutiny

Raphael Nudelman, Grace Kocks, Bruno Mouton et al. · Organic Process Research & Development · 2023 · 79 citations · Full text

, , +13

Avoiding N-nitrosodimethylamine formation in metformin pharmaceuticals by limiting dimethylamine and nitrite

Joerg Schlingemann, Céline Boucley, Sebastian Hickert et al. · International Journal of Pharmaceutics · 2022 · 67 citations · Full text

, , +14

NDMA analytics in metformin products: Comparison of methods and pitfalls

Matthias Fritzsche, Giorgio Blom, Judith Keitel et al. · European Journal of Pharmaceutical Sciences · 2021 · 44 citations · Full text

, , +15

1–5 of 8